secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2024-10-23T23:59:59+00:00
Accession:  0001567264-24-000045
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics grants stock options to CFO (427k shares) and controller (70k shares) at $3.44
--------------------------------------------------------------------------------

- Options to CFO Joseph Talamo cover 427,379 shares; to Principal Accounting Officer John Wesolowski cover 70,028 shares.
- Exercise price $3.44 per share, equal to fair market value on grant date (Oct 21, 2024).
- Options vest in five equal annual installments beginning on the grant date.
- Granted under the Company's 2021 Stock Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726424000045/0001567264-24-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726424000045/intensity-20241021.htm
  HTML page:      https://secwatch.observer/filing/0001567264-24-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer